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Clinics 
Age and sex 
69 years old female patient. 
Previous history 
No preleukemia ; no previous malignancy ; no inborn 
condition of note. 
Organomegaly 
no hepatomegaly , splenomegaly , no enlarged lymph 
nodes , no central nervous system involvement (there 
was no apparent central nervous system involvement at 
diagnosis). 
Blood 
WBC : 15.2X 109/l 
HB : 11.7g/dl 
Platelets : 894X 109/l 
Blasts : 0% peripheral 













Date of diagnosis: 03-2005 
Treatment: Phlebotomy 
Complete remission : NA 
Treatment related death : no  
Relapse : NA 
Status: Alive. Last follow up: 03-2010 
Survival: 62 months 
Karyotype 
Sample: Bone marrow biopsy Sep 17th 2009. 
Culture time: analysis was performed on overnight 
colcemid and 24-hour cultures. 
Banding: 400 band level. 
Results: 
46,XX,+9,der(9;18)(p10;q10)[11]/46,XX[9] 
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Karyotype of a metaphase from the follow up specimen from 
September 2009 (four years after the initial diagnosis), 24-hour 
culture. 
 
FISH confirmation for an extra copy of 9p. 
Comments 
We describe a new case of der(9;18)(p10;q10) detected 
in a patient with polycythemia vera (PV). This rare 
rearrangement has been reported in five cases of PV 
and one case of therapy associated acute myeloid 
leukemia (t-AML) after essential thrombocythemia 
(ET). Two of the five cases of PV showed progression 
from PV to post-polycythemic fibrosis, suggesting an 
association between this cytogenetic abnormality and
disease progression. 
The patient presented in this report was diagnosed with 
PV in 2005. Fluorescence In Situ Hybridization (FISH) 
testing for the BCR/ABL translocation was performed 
at diagnosis and was negative. Subsequent molecular 
analysis detected the presence of the JAK2 V617F 
mutation. The patient had a bone marrow biopsy in 
September of 2009, due to worsening anemia which 
was at that time attributed to excessive phlebotomy. 
Cytogenetic analysis showed the presence of the 
der(9;18)(p10;q10) in eleven out of twenty analyzed 
cells. At the later follow-up visit in February 2010, 
progression to the spent phase of PV was suspected, 
based on the worsening of the patient's clinical 
presentation. However, the next bone marrow biopsy 
from March 2010 only revealed mildly increased 
reticulin fibrosis. In summary, although the patien 
currently does not have pathohistological signs of 
progression, clinically she is exhibiting worsening of 
the disease. 
Gain of function of the JAK2 gene at 9p24 has a crucial 
role in the pathogenesis of myeloproliferative 
neoplasms. It has been proposed that the 
der(9;18)(p10;q10) contributes to the pathogenesis of 
PV through the gain of 9p, leading to an extra copy f 
the JAK2 gene. For the patient presented in this report 
the clinical significance of the der(9;18)(p10;q10) 
cannot be fully interpreted due to the absence of the 
cytogenetic results at diagnosis. However, concurrence 
between the detection of this cytogenetic abnormality 
and worsening of the patient's symptoms suggests tha  
the der(9;18)(p10;q10) may have been an early marker 
of the disease evolution. 
Gain of 9p resulting from +i(9)(p10) has been reported 
in two cases of PV, further indicating this gain as a 
recurrent finding in PV. Our patient is known to carry 
the activating JAK2 V617F mutation. One can 
hypothesize that in combination with this mutation, 
gain of an extra copy of either the mutated or the 
normal JAK2 allele through formation of the 
der(9;18)(p10;q10) contributed to the progression of 
the patient's disease. Our report therefore further 
suggests the association between the unbalanced 
rearrangement der(9;18)(p10;q10) and an advanced 
stage of polycythemia vera. 
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